Company profile: TomoTherapy
1.1 - Company Overview
Company description
- Provider of advanced radiation therapy solutions that are developed, manufactured, distributed, marketed and sold for treating a wide variety of cancers. Its ring gantry-based TomoTherapy platform combines integrated CT imaging with conformal radiation therapy to deliver sophisticated radiation treatments with speed.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to TomoTherapy
Naviscan
HQ: United States
Website
- Description: Provider of organ-specific molecular imaging, designing, manufacturing, and distributing high-resolution PET scanners that provide unprecedented visualization of small body parts and can image virtually any body part that fits into the gantry.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Naviscan company profile →
Femasys
HQ: United States
Website
- Description: Provider of medical device R&D and manufacturing for women’s healthcare, offering FemCerv, an FDA-cleared endocervical sampler; FemBloc, a nonsurgical in-office procedure for permanent contraception via fallopian tube blockage with a biopolymer using a proprietary delivery platform; and FemVue, an FDA-cleared product for real-time fallopian tube evaluation using saline and air contrast with ultrasound in a GYN’s office.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Femasys company profile →
Immunis AI
HQ: United States
Website
- Description: Provider of non-invasive, blood-based Active Surveillance Tests for active surveillance and early detection of diseases, initially validated for prostate cancer with future applications in other urological cancers.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Immunis AI company profile →
GigaGen
HQ: United States
Website
- Description: Provider of recombinant biotherapeutic discovery and development, advancing a pipeline of first-in-class biotherapeutics, including novel oncology antibody drug combinations and the world's first recombinant polyclonal hyperimmune gammaglobulin.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full GigaGen company profile →
DiaCarta
HQ: United States
Website
- Description: Provider of precision molecular diagnostics, including CE/IVD-marked KRAS detection, for cancer screening, monitoring, and therapy guidance. Offerings include RadTox for real-time cfDNA treatment response; ColoScape for colorectal screening and FIT-positive triage via plasma cfDNA changes; QClamp for sensitive ctDNA mutation detection; OptiSeq Colorectal Cancer NGS Panel for actionable mutations; Oncuria urine biomarkers; and custom mini-MRD panels.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full DiaCarta company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for TomoTherapy
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to TomoTherapy
2.2 - Growth funds investing in similar companies to TomoTherapy
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for TomoTherapy
4.2 - Public trading comparable groups for TomoTherapy
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →